The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey

Cephalalgia

Volumn 36, Issue 2, 2016, Pages 194-198

  Di Lorenzo, C ^a   Coppola, G ^b   Di Lorenzo, G ^c   Bracaglia, M ^d   Rossi, P ^e   Pierelli, F ^d,f  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b GB Bietti Foundation IRCCS   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e INI Grottaferrata   (Italy)

^f IRCCS NEUROMED   (Italy)

Author keywords

Cluster headache; illicit drugs; LSA; LSD; psilocybin

Indexed keywords

4 LYSERGIC ACID DIETHYLAMIDE; CANNABINOID; COCAINE; DIAMORPHINE; ILLICIT DRUG; LYSERGIC ACID; LYSERGIC ACID AMIDE; PSILOCYBINE; SUMATRIPTAN; UNCLASSIFIED DRUG; STREET DRUG;

ARTICLE; CLUSTER HEADACHE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; ONLINE SYSTEM; OUTCOME ASSESSMENT; PATIENT ABANDONMENT; PATIENT ATTITUDE; PATIENT SAFETY; PATIENT SATISFACTION; QUESTIONNAIRE; SELF MEDICATION; ITALY; SOCIAL MEDIA; UTILIZATION;

CLUSTER HEADACHE; FEMALE; HUMANS; ITALY; MALE; SELF MEDICATION; SOCIAL MEDIA; STREET DRUGS; SURVEYS AND QUESTIONNAIRES;

EID: 84955293002     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102415583145     Document Type: Article

References (12)

1. Rossi P, Torelli P, Di Lorenzo C, et al. Use of complementary and alternative medicine by patients with cluster headache: Results of a multi-centre headache clinic survey. Complement Ther Med 2008; 16: 220-227.
2. Rossi P, Allena M, Tassorelli C, et al. Illicit drug use in cluster headache patients and in the general population: A comparative cross-sectional survey. Cephalalgia 2012; 32: 1031-1040.
3. Di Lorenzo C, Coppola G, Pierelli F,. A case of cluster headache treated with rotigotine: Clinical and neurophysiological correlates. Cephalalgia 2013; 33: 1272-1276.
4. McGeeney BE,. Hallucinogens and cannabinoids for headache. Headache 2012; 52 (Suppl 2): 94-97.
5. Rozen TD, Fishman RS,. Inhaled oxygen and cluster headache sufferers in the United States: Use, efficacy and economics: Results from the United States Cluster Headache Survey. Headache 2011; 51: 191-200.
6. Rozen TD, Fishman RS,. Cluster headache in the United States of America: Demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache 2012; 52: 99-113.
7. Rozen TD, Fishman RS,. Female cluster headache in the United States of America: What are the gender differences? Results from the United States Cluster Headache Survey. J Neurol Sci 2012; 317: 17-28.
8. Heltsley R, DePriest A, Black DL, et al. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. J Anal Toxicol 2011; 35: 529-540.
9. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1564-1574.
10. Di Lorenzo C, Di Lorenzo G, Santorelli FM,. Pharmacogenomics and medication overuse headache: When the cure may turn to poison. Pharmacogenomics 2009; 10: 1557-1559.
11. Di Lorenzo C, Sances G, Di Lorenzo G, et al. The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett 2007; 424: 179-184.
12. Di Lorenzo C, Di Lorenzo G, Sances G, et al. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 2009; 10: 349-355.